How much does it cost to start a peptide company?

There is no single startup figure, and any supplier who hands you one is guessing. What actually sets the number is the model you choose: building or contracting synthesis and analytical testing yourself, or sourcing finished, independently tested inventory through a wholesale program. The first model front-loads capital into equipment, lab work, batch documentation and minimum commitments. The second converts most of that into a per-unit cost you only pay when you place an order. Before you budget a number, budget the categories — that is the part you can control.

Why a flat startup figure is the wrong thing to chase

Ask five operators what they spent launching a research-compound catalog and you will get five unrelated answers, because they were not buying the same thing. One built a storefront around a handful of well-known compounds and drop-shipped nothing. One committed capital to a broad catalog and warehoused it. One spent more on attorney review and insurance underwriting than on inventory. None of those numbers transfers to your situation, and a published average would be fiction dressed as guidance.

The useful question is structural: which cost layers apply to my model, which are one-time versus recurring, and which of them disappear — or convert from fixed capital into variable cost — if I source finished inventory instead of producing it?

That reframe matters because fixed costs are what kill early-stage operators. A recurring per-unit cost scales down when orders are slow. A synthesis commitment, a lab retainer, or a warehouse lease does not. The cheapest viable launch is almost always the one with the fewest fixed obligations, and the wholesale-sourcing model exists precisely to strip those obligations out of the first year.

The cost stack, layer by layer

Every peptide business, regardless of size, pays into some version of the following stack. Price each one against your own quotes — not against a number you read online.

Entity and administrative setup. Formation, registered agent, business banking, bookkeeping. Fees vary by jurisdiction and are published by the relevant authority; look them up rather than estimating.

Legal review. Counsel to review your entity structure, supplier agreements, site disclaimers, labeling language and marketing claims. This is the layer newcomers cut first and regret most, because compliant copy is far cheaper to write once than to rewrite after a complaint.

Product acquisition. Your inventory cost. Under a wholesale model this is variable and tied to volume tiers. Under a manufacturing model it becomes a set of fixed commitments long before revenue exists.

Verification and testing. Purity and identity analysis, plus screening for the contaminants that matter. If your supplier does not publish batch-matched results, you either pay for independent testing yourself or you sell inventory you cannot document.

Storage and handling. Controlled conditions, environmental monitoring, and the discipline to track lots. Storage requirements differ by compound and by format — lyophilized material and liquid presentations do not behave the same way on a shelf.

Packaging, labeling and documentation. Research-use-only labeling, lot traceability, and inserts. Relabeling an entire order because the first run was non-compliant is a pure loss.

Site, payments and insurance. Ecommerce build, and payment processing that will likely be underwritten as elevated risk — expect scrutiny, documentation requests, and the possibility of reserves. General liability and product liability coverage should be quoted by a broker who understands the category.

Fulfillment and support. Shipping materials, carrier accounts, returns handling, and the labor to answer buyer questions accurately.

Build it or source it: where the money actually goes

The single largest fork in your budget is whether you take on production and quality control or buy finished goods that already carry documentation.

The table is not an argument that manufacturing is wrong. It is an argument that manufacturing is a second-stage decision. Operators who move into production usually do it after demand is proven, not while they are still discovering which compounds their buyers reorder.

Where new-entrant budgets quietly break

The overruns are rarely in the obvious places. They cluster here:

Testing you have to repeat. If a supplier will not release a certificate of analysis tied to the exact lot in your hands, the honest options are to test it independently or to stop selling it. Suppliers who sell COA access as an add-on, or who publish a single historical result and call it coverage, are transferring their testing cost onto your balance sheet.

Inventory that ages out. Broad catalogs look impressive and tie up cash. Depth on a small number of compounds your buyers actually reorder outperforms breadth almost every time in year one.

Payment processing friction. Underwriting in this category is not routine. Reserves, rolling holds and account reviews are all realistic outcomes, and they hit working capital rather than the P&L. Budget for cash you cannot immediately touch.

Compliance rework. Marketing copy written without review is the most common source of unplanned legal spend. Research-use-only framing has to be consistent across product pages, email, packaging and paid ads — fixing it retroactively costs more than writing it correctly.

Fulfillment leakage. Packaging that fails in transit, undersized carrier accounts, and manual order handling all erode margin invisibly until volume makes them obvious.

The legal and licensing questions to price into your budget

This section is informational and is not legal advice. Nothing here substitutes for an attorney licensed in your jurisdiction.

Licensing and permitting for businesses that stock and resell research compounds is not uniform, and you should not assume the framework that applies to a business in one state applies to yours. Rather than looking for a settled answer online, treat the following as the agenda for a paid hour with counsel:

• What business licenses, permits or registrations does my state require for an entity that stocks and resells research-use-only materials, and does that answer change if I hold inventory versus route orders through a supplier?
• Which agency or board has jurisdiction over my activity, and what does it require me to document?
• What labeling and disclaimer language must appear on product, packaging and site, and who reviews it before launch?
• What are the boundaries on marketing claims for research-use-only materials, and how should my copy be constrained?
• What recordkeeping — lot traceability, customer verification, COA retention — should I be able to produce on request?
• What insurance does my exposure actually call for, and how should supplier agreements allocate liability?

Budget for those answers before you budget for inventory. An attorney and, where relevant, your state board are the only sources that can tell you what applies to your specific operation. A supplier — including any supplier promising you a shortcut — cannot.

Diligence that costs nothing and protects the most capital

Before you commit a dollar to any supplier, run the same checks you would run on a manufacturing partner. They are free, and they are the highest-leverage spend-avoidance available to a new operator.

Ask whether wholesale pricing tiers are visible before you apply, or only after a sales conversation. Hidden pricing is a negotiating posture, not a service. Ask whether certificates of analysis are published and freely viewable, or gated behind a request or a fee. Ask which analytical method the purity figure comes from, and what else the batch was screened for beyond purity — a purity number alone tells you nothing about contaminants. Ask whether the COA you can view is matched to the lot you would receive. Ask where fulfillment originates and what the stated lead time is, because transit time is inventory cost. Ask what the application process involves and how long approval takes.

A supplier who answers all of those plainly is a supplier whose costs you can model. One who deflects on any of them is introducing a cost you cannot see yet.

What Real Peptides does differently

Real Peptides supplies research-use-only compounds to businesses through its Wholesale Partner Program, and the program is built around removing the verification burden from the buyer's cost stack rather than adding to it.

Compounds are supplied at 99%+ HPLC purity. Every batch goes through 7-panel testing rather than a purity check alone. The resulting certificates of analysis are publicly verifiable — a prospective partner can read the lab results before applying, without paying for access or filing a request, and can match documentation to the material received. Fulfillment is handled domestically, with orders shipping in 5–7 days, which is a schedule you can plan reorders against instead of guessing at customs and transit variability.

Access runs through a straightforward 3-step wholesale application: submit your business details, get reviewed for approval, and receive tiered pricing for ordering. There is no requirement to complete a sales cycle before seeing what you would pay.

Catalog breadth matters when you are still learning what your buyers reorder, and stocking decisions are easier when the range is already tested and documented — from widely requested compounds such as BPC-157 and GHK-Cu through to grouped research selections like the Metabolic Research Bundle, with the full popular peptides range available to approved partners. All materials are supplied for laboratory research use only and are not FDA-approved drugs.

Turning a budget into a first order

If you have priced your entity, legal review, insurance and fulfillment layers and the remaining variable is inventory, you are at the point where a real quote beats another round of estimating. Build your first order narrow and deep, confirm the documentation before you list anything, and let reorder data — not a spreadsheet projection — tell you where to expand. Businesses that meet the criteria can move straight to the application and see tiered pricing without a sales call.

More detail on tier structure, testing and partner requirements is available on the wholesale peptides program page, and qualified businesses can apply for a wholesale account directly.